Cargando…

A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease

There have been no longitudinal studies on α-synuclein as a potential biomarker for the progression of Parkinson's disease (PD). Here, blood plasma ‘total α-synuclein’ and ‘Ser-129 phosphorylated α-synuclein’ were assayed at 4–6 monthly intervals from a cohort of 189 newly-diagnosed patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foulds, Penelope G., Diggle, Peter, Mitchell, J. Douglas, Parker, Angela, Hasegawa, Masato, Masuda-Suzukake, Masami, Mann, David M. A., Allsop, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756331/ https://www.ncbi.nlm.nih.gov/pubmed/23985836 http://dx.doi.org/10.1038/srep02540

Ejemplares similares

Prion-like spreading of pathological α-synuclein in brain
por: Masuda-Suzukake, Masami, et al.
Publicado: (2013)

Phosphorylation of endogenous α-synuclein induced by extracellular seeds initiates at the pre-synaptic region and spreads to the cell body
por: Awa, Shiori, et al.
Publicado: (2022)

Progression of phosphorylated α‐synuclein in Macaca fuscata
por: Kawakami, Ito, et al.
Publicado: (2021)

Propagation of pathological α-synuclein in marmoset brain
por: Shimozawa, Aki, et al.
Publicado: (2017)

Pathological alpha-synuclein propagates through neural networks
por: Masuda-Suzukake, Masami, et al.
Publicado: (2014)

α-Synuclein Interacts with Lipoproteins in Plasma
por: Emamzadeh, Fatemeh Nouri, et al.
Publicado: (2017)

Silver staining (Campbell-Switzer) of neuronal α-synuclein assemblies induced by multiple system atrophy and Parkinson’s disease brain extracts in transgenic mice
por: Lavenir, Isabelle, et al.
Publicado: (2019)

Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril
por: Kim, Changyoun, et al.
Publicado: (2016)

Ubiquitination of alpha-synuclein filaments by Nedd4 ligases
por: Mund, Thomas, et al.
Publicado: (2018)

Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds
por: Macdonald, Jennifer A., et al.
Publicado: (2021)

Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons
por: Urrea, Laura, et al.
Publicado: (2017)

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
por: Foulds, P.G., et al.
Publicado: (2012)

α-Synuclein filaments from transgenic mouse and human synucleinopathy-containing brains are major seed-competent species
por: Morgan, Sophie A., et al.
Publicado: (2020)

Dextran sulphate-induced tau assemblies cause endogenous tau aggregation and propagation in wild-type mice
por: Masuda-Suzukake, Masami, et al.
Publicado: (2020)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Apathy as a behavioural marker of cognitive impairment in Parkinson’s disease: a longitudinal analysis
por: Martin, Glen P., et al.
Publicado: (2019)

Longitudinal Analyses of Cerebrospinal Fluid α-Synuclein in Prodromal and Early Parkinson’s Disease
por: Mollenhauer, Brit, et al.
Publicado: (2019)

Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
por: Hosokawa, Masato, et al.
Publicado: (2012)

Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson’s Disease
por: Chung, Chen-Chih, et al.
Publicado: (2021)

Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
por: Tarutani, Airi, et al.
Publicado: (2022)

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
por: Smith, Lynnae M., et al.
Publicado: (2012)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Correction to: Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
por: Tarutani, Airi, et al.
Publicado: (2022)

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
por: Winslow, Ashley R., et al.
Publicado: (2010)

TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration
por: Foulds, Penelope, et al.
Publicado: (2008)

A Cellular Model To Monitor Proteasome Dysfunction by α-Synuclein†
por: Nonaka, Takashi, et al.
Publicado: (2009)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
por: Garretti, Francesca, et al.
Publicado: (2019)

Longitudinal Metabolomics Profiling of Parkinson’s Disease-Related α-Synuclein A53T Transgenic Mice
por: Chen, Xi, et al.
Publicado: (2015)

Role of cytochrome c in α-synuclein radical formation: implications of α-synuclein in neuronal death in Maneb- and paraquat-induced model of Parkinson’s disease
por: Kumar, Ashutosh, et al.
Publicado: (2016)

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
por: Tian, Chen, et al.
Publicado: (2019)

Can Plasma α-Synuclein Help Us to Differentiate Parkinson’s Disease from Essential Tremor?
por: Albillos, Silvia M., et al.
Publicado: (2021)

αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease?
por: Protter, David, et al.
Publicado: (2012)

Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer’s disease brain
por: Dan, Ayaho, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_18dhfqlqc7bvknt60j22l8g85i